Prevalence of biofilm producing Acinetobacter baumannii clinical isolates: A systematic review and meta-analysis.
Alemu GedefieErmiyas AlemayehuOusman MohammedGetachew Mesfin BamboSamuel Sahile KebedeBerhanu KebedePublished in: PloS one (2023)
The pooled prevalence of biofilm-producing A. baumannii clinical isolates has risen alarmingly, posing a public health risk. This indicates the burden of biofilm-producing A. baumannii infections urges routine screening and appropriate treatment for better management of hospitalized patients, as well as effective controlling of the emergence of drug resistance. Furthermore, this finding is an alert call for the stakeholders to develop strong infection prevention and antibiotics stewardship programs for the prevention and control of biofilm-producing bacterial infections.
Keyphrases
- pseudomonas aeruginosa
- acinetobacter baumannii
- staphylococcus aureus
- candida albicans
- health risk
- biofilm formation
- cystic fibrosis
- risk factors
- multidrug resistant
- drug resistant
- healthcare
- drinking water
- public health
- mental health
- clinical trial
- combination therapy
- randomized controlled trial
- risk assessment
- clinical decision support
- double blind